School of Medicinal and Health Products Sciences, University of Camerino, Camerino, Italy.
Asur Marche, Area Vasta 4, Fermo, Italy.
Diabetes Res Clin Pract. 2020 Nov;169:108481. doi: 10.1016/j.diabres.2020.108481. Epub 2020 Sep 28.
The recent COVID-19 pandemic has accelerated the treatment process through IT/technological supports, useful in the management of chronic patients such as those affected by type 1 Diabetes Mellitus (T1DM). Specific routes for fragile patients such as those with micro-infusers have been created thanks to the application of "Diabetes Technology," which allows patients to monitor blood glucose quickly and easily. The present pilot study aimed to assess the quality of care provided to patients with micro-infusers in a delicate phase such as a pandemic lockdown.
A mixed-methods approach was used. In the first part, with prior written consent, patients with insulin pumps enrolled voluntarily. In the second part, the focus group discussion (FGD) was carried out with the voluntarily enrolled participants. The FGD data were organized and analyzed by the thematic areas.
The number of patients with afferent insulin pumps at the center was 50 individuals. Among them, 20 patients voluntarily joined the first part of the study by completing the PACIC questionnaire, which gave an average result of 3.34 (min. 2.2 and max. 4.2). In the second part, the application of the focus group technique demonstrated that technology is decisive in the management of diabetic pathology, not only in the emergency phase.
At the time of public health crises, alternative strategies such as Tele-Nursing or Telemedicine could be crucial for the management of patients with micro-infuser not only in critical moments, such as lockdown, but also in ordinary health management.
最近的 COVID-19 大流行通过 IT/技术支持加速了治疗过程，这对于管理 1 型糖尿病 (T1DM) 等慢性病患者非常有用。由于“糖尿病技术”的应用，为微输注器等脆弱患者开辟了特定的治疗途径，使患者能够快速轻松地监测血糖。本试点研究旨在评估在大流行封锁等脆弱阶段为微输注器患者提供的护理质量。
采用混合方法。在第一部分，在事先书面同意的情况下，自愿招募使用胰岛素泵的患者。在第二部分，对自愿参加的参与者进行焦点小组讨论 (FGD)。通过主题领域对 FGD 数据进行组织和分析。
该中心使用胰岛素输注泵的患者人数为 50 人。其中，20 名患者自愿通过填写 PACIC 问卷参加了研究的第一部分，平均得分为 3.34（最小值为 2.2，最大值为 4.2）。在第二部分，焦点小组技术的应用表明，技术在糖尿病病理管理中至关重要，不仅在紧急阶段。
在公共卫生危机时期，远程护理或远程医疗等替代策略对于管理微输注器患者可能至关重要，不仅在封锁等关键时刻，而且在常规健康管理中也是如此。
